Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
The DOI matches its Crossref record.
Abstract
The classifications of hepatocellular carcinoma (HCC) currently used are based on prognostic factors obtained from studies performed years ago when most tumors were diagnosed at advanced stages and the survival rates were substantially poor. Recent investigations have reviewed the survival of early tumors properly selected to receive radical therapies and the natural outcome of nonsurgical HCC patients. These data enable a new staging system to be proposed, the Barcelona Clinic Liver Cancer (BCLC) staging classification, that comprises four stages that select the best candidates for the best therapies currently available. Early stage (A) includes patients with asymptomatic early tumors suitable for radical therapies--resection, transplantation or percutaneous treatments. Intermediate stage (B) comprises patients with asymptomatic multinodular HCC. Advanced stage (C) includes patients with symptomatic tumors and/or an invasive tumoral pattern (vascular invasion/extrahepatic spread). Stage B and C patients may receive palliative treatments/new agents in the setting of phase II investigations or randomized controlled trials. End-stage disease (D) contain patients with extremely grim prognosis (Okuda stage III or PST 3-4) that should merely receive symptomatic treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The management of patients with HCC has improved markedly since the first BCLC classification was proposed in 1999143.”
From Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma (2024) · cites this paper as [143]
Citations
Cites
Still being checked.
Cited by
Items 401–500 of 1,005
Sarcopenia is a risk factor for the recurrence of hepatocellular carcinoma after curative treatment
Kamachi, S., Mizuta, T., Otsuka, T., Nakashita, S., Ide, Y., Miyoshi, A., Kitahara, K., Eguchi, Y., Ozaki, I., & Anzai, K. (2016) · Hepatology Research · doi:10.1111/hepr.12562 · Cited by 96
Systematic review of surgical resectionvsradiofrequency ablation for hepatocellular carcinoma
Cucchetti, A., Piscaglia, F., Cescon, M., Ercolani, G., & Pinna, A. D. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i26.4106 · Cited by 101
Skin toxicities and survival in advanced hepatocellular carcinoma patients treated with sorafenib
Otsuka, T., Eguchi, Y., Kawazoe, S., Yanagita, K., Ario, K., Kitahara, K., Kawasoe, H., Kato, H., Mizuta, T., & the Saga Liver Cancer Study Group (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.00991.x · Cited by 100
McEvoy, S. H., McCarthy, C. J., Lavelle, L. P., Moran, D. E., Cantwell, C. P., Skehan, S. J., Gibney, R. G., & Malone, D. E. (2013) · Radiographics · doi:10.1148/rg.336125104 · Cited by 100
Rich, N. E., Carr, C. L., Yopp, A. C., Marrero, J. A., & Singal, A. G. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.12.029 · Cited by 100
Livraghi, T., Meloni, M. F., Morabito, A., & Vettori, C. (2004) · Liver Transplantation · doi:10.1002/lt.20053 · Cited by 100
Takagi, K., Yagi, T., Umeda, Y., Shinoura, S., Yoshida, R., Nobuoka, D., Kuise, T., Araki, H., & Fujiwara, T. (2017) · World Journal of Surgery · doi:10.1007/s00268-017-3985-8 · Cited by 99
Petrillo, M., Patella, F., Pesapane, F., Suter, M. B., Ierardi, A. M., Angileri, S. A., Floridi, C., Filippo, M. D., & Carrafiello, G. (2018) · Future Oncology · doi:10.2217/fon-2017-0739 · Cited by 99
Kuo, Y., Lu, S., Chen, C., Cheng, Y., Lin, C., Hung, C., Chen, C., Changchien, C., Hsu, H., Hu, T., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.12.018 · Cited by 99
Kee, K., Wang, J., Lee, C., Chen, C., Changchien, C., Hu, T., Cheng, Y., Hsu, H., Wang, C., Chen, T., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22616 · Cited by 99
Staging of Hepatocellular Carcinoma
Duseja, A. K. (2014) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2014.03.045 · Cited by 99
Bonomo, G., Pedicini, V., Monfardini, L., Vigna, P. D., Poretti, D., Orgera, G., & Orsi, F. (2009) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-009-9752-y · Cited by 99
Kokudo, T., Hasegawa, K., Amikura, K., Uldry, É., Shirata, C., Yamaguchi, T., Arita, J., Kaneko, J., Akamatsu, N., Sakamoto, Y., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159530 · Cited by 98
Multimodal treatment of hepatocellular carcinoma
Graf, D., Vallböhmer, D., Knoefel, W. T., Kröpil, P., Antoch, G., Sagir, A., & Häussinger, D. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.03.001 · Cited by 97
Xing, H., Zhang, W., Cescon, M., Liang, L., Li, C., Wang, M.-D., Wu, H., Lau, W. Y., Zhou, Y.-H., Gu, W.-M., et al. (2019) · HPB · doi:10.1016/j.hpb.2019.09.006 · Cited by 97
Iwamoto, H., Shimose, S., Shirono, T., Niizeki, T., & Kawaguchi, T. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0391 · Cited by 97
Kobayashi, M., Ikeda, K., Kawamura, Y., Yatsuji, H., Hosaka, T., Sezaki, H., Akuta, N., Suzuki, F., Suzuki, Y., Saitoh, S., et al. (2009) · Cancer · doi:10.1002/cncr.24031 · Cited by 97
Chen, X., Zhai, J., Cai, X., Zhang, Y., Wei, L., Shi, L., Wu, D., Shen, F., Wy, L., & Wu, M. (2012) · British journal of surgery · doi:10.1002/bjs.8951 · Cited by 97
Wiggermann, P., Sieroń, D., Brosche, C., Brauer, T., Scheer, F., Platzek, I., Wawrzynek, W., & Stroszczynski, C. (2011) · Medical Science Monitor · doi:10.12659/msm.881714 · Cited by 97
Dietrich, C. F., Lorentzen, T., Appelbaum, L., Buscarini, E., Cantisani, V., Corréas, J.-M., Cui, X., D’Onofrio, M., Gilja, O. H., Hocke, M., et al. (2015) · Ultraschall in der Medizin - European Journal of Ultrasound · doi:10.1055/s-0035-1553917 · Cited by 97
The changing scenario of hepatocellular carcinoma over the last two decades in Italy
Santi, V., Buccione, D., Micoli, A. D., Fatti, G., Frigerio, M., Farinati, F., Poggio, P. D., Rapaccini, G., Nolfo, M. A. D., Benvegnù, L., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.05.026 · Cited by 96
Locoregional and systemic therapy for hepatocellular carcinoma
Gbolahan, O. B., Schacht, M. A., Beckley, E. W., LaRoche, T. P., O’Neil, B. H., & Pyko, M. (2017) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2017.03.13 · Cited by 96
Mähringer‐Kunz, A., Steinle, V., Düber, C., Weinmann, A., Koch, S., Schmidtmann, I. M., Schotten, S., Hinrichs, J. B., Graafen, D., dos Santos, D. P., et al. (2018) · Liver International · doi:10.1111/liv.13988 · Cited by 96
Systemic therapy of liver cancer
Demir, T., Lee, S. S., & Kaseb, A. O. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2020.12.001 · Cited by 97
Digestive cancers: mechanisms, therapeutics and management
Zhan, T., Betge, J., Schulte, N., Dreikhausen, L., Hirth, M., Li, M., Weidner, P., Leipertz, A., Teufel, A., & Ebert, M. P. A. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02097-4 · Cited by 100
The Autophagy-Related Marker LC3 Can Predict Prognosis in Human Hepatocellular Carcinoma
Lee, Y. J., Ha, Y. J., Kang, Y. N., Kang, K. J., Hwang, J. S., Chung, W. J., Cho, K. B., Park, K. S., Kim, E. S., Seo, H.-Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081540 · Cited by 96
Finkelmeier, F., Kronenberger, B., Köberle, V., Bojunga, J., Zeuzem, S., Trojan, J., Piiper, A., & Waidmann, O. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12731 · Cited by 97
Farinati, F., Sergio, A., Baldan, A., Giacomin, A., Nolfo, M. A. D., Poggio, P. D., Benvegnù, L., Rapaccini, G., Zoli, M., Borzio, F., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-33 · Cited by 96
Kudo, M., Finn, R. S., Galle, P. R., Zhu, A. X., Ducreux, M. P., Cheng, A., Ikeda, M., Tsuchiya, K., Aoki, K.-I., Jia, J., et al. (2022) · Liver Cancer · doi:10.1159/000528272 · Cited by 96
Minimally invasive local therapies for liver cancer.
Li, D., Kang, J., Golas, B. J., Yeung, V. W., & Madoff, D. C. (2014) · PubMed Central · doi:10.7497/j.issn.2095-3941.2014.04.001 · Cited by 95
Lu, X., Xi, T., Lau, W. Y., Dong, H. F., Xian, Z., Yu, H., Zhu, Z., Shen, F., Wu, M., & Cong, W. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0909-5 · Cited by 95
Ye, J., Chen, J.-Z., Li, Z., Bai, T., Chen, J., Zhu, S., Li, L., & Wu, F. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i41.7415 · Cited by 94
Suddle, A. R., Reeves, H. L., Hubner, R. A., Marshall, A., Rowe, I. A. C., TINIAKOS, D. G., Hübscher, S. G., Callaway, M. P., Sharma, D., See, T. C., et al. (2024) · Gut · doi:10.1136/gutjnl-2023-331695 · Cited by 95
Zhou, L., Rui, J., Ye, D., Wang, S., Chen, S., & Qu, Q. (2008) · World Journal of Surgery · doi:10.1007/s00268-008-9615-8 · Cited by 95
Ishizuka, M., Kubota, K., Kita, J., Shimoda, M., Kato, M., & Sawada, T. (2011) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2010.09.030 · Cited by 94
Song, P., Cai, Y., Tang, H., Li, C., & Huang, J. (2017) · BioScience Trends · doi:10.5582/bst.2017.01202 · Cited by 93
Liu, B., Zhang, J., Huang, C. L., & Liu, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043147 · Cited by 97
Current Management of Hepatocellular Carcinoma
Mendizábal, M., & Reddy, K. R. (2009) · Medical Clinics of North America · doi:10.1016/j.mcna.2009.03.004 · Cited by 93
Giannini, E. G., Risso, D., Testa, R., Trevisani, F., Nolfo, M. A. D., Poggio, P. D., Benvegnù, L., Rapaccini, G. L., Farinati, F., Zoli, M., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.08.011 · Cited by 93
Diagnóstico y tratamiento del carcinoma hepatocelular
Forner, A., Ayuso, C., Real, M. I., Sastre, J., Robles-Campos, R., Sangro, B., Varela, M., de la Mata, M., Buti, M., Martí‐Bonmatí, L., et al. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2008.11.024 · Cited by 93
Self-citationDoffoël, M., Bonnetain, F., Bouché, O., Vetter, D., Abergel, A., Fratté, S., Grangé, J., Stremsdoerfer, N., Blanchi, A., Bronowicki, J., et al. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.01.004 · Cited by 93
Diagnostic and therapeutic management of hepatocellular carcinoma
Bellissimo, F., Pinzone, M. R., Cacopardo, B., & Nunnari, G. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i42.12003 · Cited by 93
Golfieri, R., Bargellini, I., Spreafico, C., & Trevisani, F. (2018) · Liver Cancer · doi:10.1159/000489791 · Cited by 92
Wang, H., Du, P., Wu, M.-C., & Cong, W. (2018) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2018.09.05 · Cited by 93
Chan, S. L., Mo, F. K. F., Johnson, P. J., Liem, G. S., Chan, T. C., Poon, M. C., Ma, B. B. Y., Leung, T. W. T., Lai, P. B. S., Chan, A. T. �., et al. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06329.x · Cited by 92
Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study
Cabibbo, G., Maida, M. F., Genco, C., Parisi, P. S., Peralta, M., Antonucci, M., Brancatelli, G., Cammà, C., Craxì, A., & Marco, V. D. (2012) · World Journal of Hepatology · doi:10.4254/wjh.v4.i9.256 · Cited by 92
Ladep, N. G., Dona, A. C., Lewis, M. R., Crossey, M. M. E., Lemoine, M., Okeke, E. N., Shimakawa, Y., Duguru, M. J., Njai, H. F., Fye, H. K. S., et al. (2014) · Hepatology · doi:10.1002/hep.27264 · Cited by 92
Kornberg, A., Küpper, B., Tannapfel, A., Büchler, P., Krause, B., Witt, U., Gottschild, D., & Frieß, H. (2011) · Liver Transplantation · doi:10.1002/lt.22416 · Cited by 91
Peretinoin Study Group, Okita, K., Izumi, N., Matsui, O., Tanaka, K., Kaneko, S., Moriwaki, H., Ikeda, K., Osaki, Y., Numata, K., et al. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-014-0956-9 · Cited by 90
“Curative resection or ablation is indicated for early HCC [5–7].”
BackgroundNiessen, C., Thumann, S., Beyer, L. P., Pregler, B., Kramer, J., Lang, S., Teufel, A., Jung, E. M., Stroszczynski, C., & Wiggermann, P. (2017) · Scientific Reports · doi:10.1038/srep43687 · Cited by 90
Ikai, I., Takayasu, K., Omata, M., Okita, K., Nakanuma, Y., Matsuyama, Y., Makuuchi, M., Kojiro, M., Ichida, T., Arii, S., et al. (2006) · Journal of Gastroenterology · doi:10.1007/s00535-006-1878-y · Cited by 90
Weng, L., Du, J., Zhou, Q.-H., Cheng, B., Li, J., Zhang, D., & Ling, C. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-39 · Cited by 90
Waked, I., Berhane, S., Toyoda, H., Chan, S. L., Stern, N., Palmer, D., Tada, T., Yeo, W., Mo, F., Bettinger, D., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2016.423 · Cited by 84
Tada, T., Kumada, T., Hiraoka, A., Michitaka, K., Atsukawa, M., Hirooka, M., Tsuji, K., Ishikawa, T., Takaguchi, K., Kariyama, K., et al. (2020) · Liver International · doi:10.1111/liv.14405 · Cited by 89
Loglio, A., Iavarone, M. A., Facchetti, F., Paolo, D. D., Perbellini, R., Lunghi, G., Ceriotti, F., Galli, C., Sandri, M. T., Viganò, M., et al. (2020) · Liver International · doi:10.1111/liv.14475 · Cited by 89
Efficacy and safety of radiotherapy for primary liver cancer
Chen, W., Chiang, C., & Dawson, L. A. (2020) · Chinese Clinical Oncology · doi:10.21037/cco-20-89 · Cited by 89
Cheng, A., Amarapurkar, D. N., Chao, Y., Chen, P., Geschwind, J.-F. H., Goh, K., Han, K., Kudo, M., Lee, H. C., Lee, R., et al. (2013) · Liver International · doi:10.1111/liv.12314 · Cited by 89
Collette, S., Bonnetain, F., Paolettí, X., Doffoël, M., Bouché, O., Raoul, J., Rougier, P. R., Masskouri, F., Bedenne, L., & Barbare, J. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn030 · Cited by 89
von Felden, J., Schulze, K., Krech, T., Ewald, F., Nashan, B., Pantel, K., Lohse, A. W., Riethdorf, S., & Wege, H. (2017) · Oncotarget · doi:10.18632/oncotarget.21208 · Cited by 88
Colli, A., Nadarević, T., Miletić, D., Giljača, V., Fraquelli, M., Štimac, D., & Casazza, G. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013346.pub2 · Cited by 88
Hsu, P. C., Federico, C. A., Krajden, M., Yoshida, E. M., Bremner, K. E., Anderson, F., Weiss, A. A., & Krahn, M. D. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06813.x · Cited by 88
Reichl, P., & Mikulits, W. (2016) · Oncology Reports · doi:10.3892/or.2016.4842 · Cited by 88
Sanghera, C., Teh, J. J., & Pinato, D. J. (2019) · Liver International · doi:10.1111/liv.14220 · Cited by 88
Recent Advances in Liver Transplantation
Wiesner, R. H., Rakela, J. L., Ishitani, M. B., Mulligan, D. C., Spivey, J. R., Steers, J. L., & Krom, R. A. F. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.2.197 · Cited by 88
Huang, Y., Zhou, S., Zhu, J., Lubman, D. M., & Mechref, Y. S. (2017) · Electrophoresis · doi:10.1002/elps.201700025 · Cited by 87
Toyoda, H., Kumada, T., Kiriyama, S., Sone, Y., Tanikawa, M., Hisanaga, Y., Yamaguchi, A., Isogai, M., Kaneoka, Y., & Washizu, J. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41943.x · Cited by 87
Olsen, S. K., Brown, R. S., & Siegel, A. B. (2009) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x09346669 · Cited by 87
Embolization of liver tumors: Past, present and future
Rammohan, A., Sathyanesan, J., Ramaswami, S., Lakshmanan, A., Senthil-Kumar, P., Srinivasan, U. P., Ramasamy, R., & Ravichandran, P. (2012) · World Journal of Radiology · doi:10.4329/wjr.v4.i9.405 · Cited by 87
Radiofrequency ablation, PEIT, and TACE for hepatocellular carcinoma
Livraghi, T. (2003) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s10534-002-0714-y · Cited by 87
Imaging in the Diagnosis, Staging, Treatment, and Surveillance of Hepatocellular Carcinoma
Szklaruk, J., Silverman, P. M., & Charnsangavej, C. (2003) · American Journal of Roentgenology · doi:10.2214/ajr.180.2.1800441 · Cited by 87
Vauthey, J., Ribero, D., Abdalla, E. K., Jonas, S., Bharat, A., Schumacher, G., Lerut, J. P., Chapman, W. C., Hemming, A. W., & Neuhaus, P. (2007) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2006.12.043 · Cited by 87
Wireless capsule endoscopy and Crohn’s disease
Swain, P. C. (2005) · Gut · doi:10.1136/gut.2004.047282 · Cited by 87
Yang, T., Lin, C., Zhai, J., Shi, S., Zhu, M., Zhu, N., Lu, J., Yang, G.-S., & Wu, M. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1188-0 · Cited by 86
Hepatocellular Carcinoma 2009 and Beyond: from the Surveillance to Molecular Targeted Therapy
Kudo, M. (2008) · Oncology · doi:10.1159/000181865 · Cited by 86
Ikai, I., Hatano, E., Hasegawa, S., Fujii, H., Taura, K., Uyama, N., & Shimahara, Y. (2006) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2005.11.012 · Cited by 86
Singal, A. G., Patibandla, S., Obi, J., Fullington, H. M., Parikh, N. D., Yopp, A. C., & Marrero, J. A. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.09.014 · Cited by 86
The evolutionary scenario of hepatocellular carcinoma in Italy: an update
Bucci, L., Garuti, F., Lenzi, B., Pecorelli, A., Farinati, F., Giannini, E. G., Granito, A., Ciccarese, F., Rapaccini, G. L., Marco, M. D., et al. (2016) · Liver International · doi:10.1111/liv.13204 · Cited by 85
Minici, R., Siciliano, M. A., Ammendola, M., Santoro, R., Barbieri, V., Ranieri, G., & Laganà, D. (2022) · Cancers · doi:10.3390/cancers15010257 · Cited by 85
Cho, S., Yoon, J., Hwang, S., & Lee, H. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04914.x · Cited by 85
Gomaa, A. I., Hashim, M. S., & Waked, I. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090929 · Cited by 85
Yang, W., Yan, K., Goldberg, S. N., Ahmed, M., Lee, J., Wu, W., Zhang, Z., Wang, S., & Chen, M. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i10.2993 · Cited by 85
Abouchaleh, N., Gabr, A., Ali, R., Asadi, A. A., Mora, R. A., Kallini, J. R., Mouli, S. K., Riaz, A., Lewandowski, R. J., & Salem, R. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.199752 · Cited by 86
Esnaola, N. F., Mirza, N. Q., Lauwers, G. Y., Ikai, I., Regimbeau, J., Belghiti, J., Yamaoka, Y., Curley, S. A., Ellis, L. M., Nagorney, D. M., et al. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000094436.34556.ac · Cited by 85
Cirrhosis is under-recognised in patients subsequently diagnosed with hepatocellular cancer
Walker, M., El‐Serag, H. B., Sada, Y., Mittal, S., Ying, J., Duan, Z., Richardson, P., Davila, J. A., & Kanwal, F. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13505 · Cited by 84
Vilar‐Gomez, E., Vuppalanchi, R., Desai, A. P., Gawrieh, S., Ghabril, M., Saxena, R., Cummings, O. W., & Chalasani, N. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15331 · Cited by 84
Lin, J., Zhang, H., Yu, H., Bi, X., Zhang, W., Yin, J., Zhao, P., Liang, X., Qu, C., Wang, M., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.906778 · Cited by 84
Takeda, H., Takai, A., Inuzuka, T., & Marusawa, H. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1273-2 · Cited by 85
Ikeda, S., Tsigelny, I. F., Skjevik, Å. A., Kono, Y., Mendler, M. H., Kuo, A., Sicklick, J. K., Heestand, G. M., Banks, K. C., Talasaz, A. H., et al. (2018) · The Oncologist · doi:10.1634/theoncologist.2017-0479 · Cited by 84
Results of liver transplantation: With or without milan criteria?
Mazzaferro, V. (2007) · Liver Transplantation · doi:10.1002/lt.21330 · Cited by 85
Diagnostic and Prognostic Molecular Markers in Hepatocellular Carcinoma
Mínguez, B., & Lachenmayer, A. (2011) · Disease Markers · doi:10.1155/2011/310675 · Cited by 83
Multimodal approaches to the treatment of hepatocellular carcinoma
Cabibbo, G., Latteri, F., Antonucci, M., & Craxì, A. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1357 · Cited by 83
Jacob, R., Turley, F., Redden, D. T., Saddekni, S., Aal, A. K. A., Keene, K. S., Yang, E. S.-H., Zarzour, J. G., Bolus, D. N., Smith, J. K., et al. (2014) · HPB · doi:10.1111/hpb.12331 · Cited by 83
Treatment and prognosis of hepatocellular carcinoma: A population based study in France
Borie, F., Bouvier, A., Herrero, A., Faivre, J., Launoy, G. D., Delafosse, P., Velten, M., Buémi, A., Peng, J., Grosclaude, P., et al. (2008) · Journal of Surgical Oncology · doi:10.1002/jso.21159 · Cited by 83
The importance of a multidisciplinary approach to hepatocellular carcinoma
Siddique, O., Yoo, E. R., Perumpail, R. B., Perumpail, B. J., Liu, A., Cholankeril, G. T., & Ahmed, A. (2017) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s128629 · Cited by 83
Pinato, D. J., Kaneko, T., Saeed, A., Pressiani, T., Kaseb, A. O., Wang, Y., Szafron, D., Jun, T. W., Dharmapuri, S., Naqash, A. R., et al. (2020) · Cancers · doi:10.3390/cancers12071862 · Cited by 83
Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances
Cucarull, B., Tutusaus, A., Rider, P., Hernáez-Alsina, T., Cuño-Gómiz, C., de Frutos, P. G., Colell, A., Marí, M., & Morales, A. (2022) · Cancers · doi:10.3390/cancers14030621 · Cited by 82
Meniconi, R. L., Komatsu, S., Perdigão, F., Boëlle, P., Soubrane, O., & Scatton, O. (2014) · Surgery · doi:10.1016/j.surg.2014.10.011 · Cited by 82
Hepatocellular Carcinoma in Pakistan: National Trends and Global Perspective
Bhatti, A. B. H., Dar, F. S., Waheed, A., Shafique, K., Sultan, F., & Shah, N. H. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/5942306 · Cited by 85
Azoulay, D., Ramos, E., Casellas‐Robert, M., Salloum, C., Lladó, L., Nadler, R., Busquets, J., Caula-Freixa, C., Mils, K., López‐Ben, S., et al. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100190 · Cited by 81
Luo, J.-J., Zhang, Z., Liu, Q., Zhang, W., Wang, J., & Yan, Z.-P. (2015) · Hepatology International · doi:10.1007/s12072-015-9663-8 · Cited by 81
Metadata
- Authors
- Llovet, J., Brú, C., & Bruix, J.
- Affiliations
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 1999
- Volume
- 19
- Issue
- 03
- Pages
- 329-338
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2147172608
- Cited by
- 3,805
- References
- 0
- Citations by year
- 2026: 70 · 2025: 117 · 2024: 162 · 2023: 211 · 2022: 269 · 2021: 280 · 2020: 279 · 2019: 215 · 2018: 206 · 2017: 218 · 2016: 216 · 2015: 220 · 2014: 219 · 2013: 163 · 2012: 154
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Keywords
- hepatocellular carcinoma, prognosis, tumor staging, radical treatment, liver transplantation, hepatectomy, percutaneous treatment, vascular invasion, extrahepatic spread, palliative care, Okuda staging
- MeSH terms
- Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Prognosis, Survival Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.